Alexandria Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Alexandria Capital's CELG Position: Q4 2017 in Review
Alexandria Capital sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 759 shares — an estimated $111K sold.
Alexandria Capital first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $130K in Q3 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Alexandria Capital reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
- Alexandria Capital sold 759 Celgene Corp shares in Q4 2017, an estimated $111K.
- Alexandria Capital first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
- Alexandria Capital's Celgene Corp position peaked at $130K in Q3 2016.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.